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ABSTRACT
Anhedonia, a diminished or lack of ability to experience and anticipate pleasure
represents a core psychiatric symptom in depression. Current clinician assessment
of anhedonia is generally limited to one or two all-purpose questions and most
well-known psychometric scales of anhedonia are relatively long, self-administered,
typically not state sensitive, and are unsuitable for use in clinical settings. A user-
friendly tool for a more in-depth clinician assessment of hedonic capacity is needed.
Thepresentstudyassessedthevalidityandreliabilityofaclinicianadministeredver-
sion of the Snaith-Hamilton Pleasure Scale, the SHAPS-C, in 34 depressed subjects.
We compared total and specific item scores on the SHAPS-C, SHAPS (self-report
version),Montgomery-˚ AsbergDepressionRatingScale(MADRS),andtheInventory
of Depressive Symptomatology-Self Rating version (IDS-SR). We also examined
construct, content, concurrent, convergent, and discriminant validity, internal con-
sistency, and split-half reliability of the SHAPS-C. The SHAPS-C was found to be
valid and reliable. The SHAPS and the SHAPS-C were positively correlated with
one another, with levels of depression severity, as measured by the MADRS, and the
IDS-SR total scores, and with specific items of the MADRS and IDS-SR sensitive
to measuring hedonic capacity. Our investigation indicates that the SHAPS-C is a
user friendly, reliable, and valid tool for clinician assessment of hedonic capacity in
depressedbipolarandunipolarpatients.
Subjects Psychiatry and Psychology
Keywords Self-assessment, Anhedonia, Depression, Clinician administered
INTRODUCTION
A diminished or lack of ability to experience or anticipate pleasure or anhedonia, and its
assessment is central to understanding and treating depressive states (Hasler et al., 2004;
Klein,1974;Robinsonetal.,2012;Spijkeretal.,2001a;Spijkeretal.,2001b;Treadway&Zald,
2011).Researchhasindicatedadistinctneurobiologicaldifferencebetweenconsummatory
and anticipatory pleasure; evidence suggests that the latter is strongly aberrant in
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DomainCriteria(NIMH,RDoC;Inseletal.,2010)considersanhedoniaacentralconstruct
for both better understanding of depression and discovery of more effective treatments
(Cuthbert, 2014). Several self-rated scales for the assessment of hedonic capacity have
been published, including the Chapman Revised Physical and Social Anhedonia Scales
(CRPAS/CRSAS; Chapman, Chapman & Raulin, 1976), the Fawcett Clark Pleasure Scale
(FCPS; Fawcett et al., 1983), and Snaith-Hamilton Pleasure Scale (SHAPS; Snaith et al.,
1995).Thelatterisa14-item,self-rateduser-friendlymeasurethataddressesshortcomings
ofpreviousmeasures,suchaslength,stateversustraitsensitivity,andtherelativelyculture
freenatureofquestions(Snaithetal.,1995),andhasbeenfurthervalidatedinindependent
samples since the original study (Franken, Rassin & Muris, 2007; Leventhal et al., 2006;
Nakoneznyetal.,2010).Furthermore,ResearchDomainCriteria(RDoC;Inseletal.,2010)
included the SHAPS as a potential measure of ‘sustained responsiveness to reward’, which
is related to anhedonia. Reliable and valid measurement of hedonic capacity will only
increaseinimportanceasRDoCisincorporatedintofutureresearch.
The SHAPS is a self-rated tool. The value of self-assessments in depressive states has
been called into question (Corruble et al., 1999; Prusoff, Klerman & Paykel, 1972a; Prusoff,
Klerman & Paykel, 1972b). While the effective use of self-assessment has been reported
(Rush et al., 1986), severity of illness, presence of personality disorders, instructions,
motivation, and mood-dependent memory are among the factors that can compromise
the objectivity of self-assessments (Blaney, 1986; Corruble et al., 1999; Prusoff, Klerman
& Paykel, 1972b). Emerging evidence from both neuroimaging work and behavioral
studies suggest that neural/behavioral responses for people with severe mental disorders
(e.g., schizophrenia) are different from their self-reported responses. For example, there
are neuroimaging data that suggest patients with schizophrenia show intact patterns
of increased ventral striatum responses to reward receipt itself (Dowd & Barch, 2012),
although they tend to report reduced ability of experiencing pleasure according to a
self-report measure of anhedonia (Kring & Moran, 2008). Furthermore, some have
suggested that a complete assessment of depression should include both clinician-rated
and self-report measures since each uniquely contribute to the prediction of treatment
outcome(Uheretal.,2012).
Based on the initial promise of the SHAPS, we modified this scale for use as a
clinician-administered tool, SHAPS-C, by adding specific item wording, instructions,
and probe questions, as well as modification of the scoring. Care was taken to phrase the
questions such that both the consummation and the anticipatory aspects of anhedonia
could be assessed. The SHAPS-C includes the same 14 areas of hedonic experience as the
SHAPS.SHAPSitemsarescored0or1.ItemsontheSHAPS-Carescoredfrom1to4(1=
Lots of pleasure, 4 = No pleasure) to allow for greater score variability (Franken, Rassin &
Muris,2007;Liuetal.,2012).Theinclusionof“lotsofpleasure”whichisscored1,canalso
allow the investigation of high moods should that be of assessment interest particularly in
bipolarconditions(SHAPS-C,seeSupplementalInformation).
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is closely modeled after the SHAPS and explores identical areas of hedonic capacity. We
further assessed the concurrent validity of the SHAPS-C by examining its relationship to
the SHAPS in a group of unipolar and bipolar depressed patients. The convergent validity
wasassessedbyexaminingtherelationshipbetweentheSHAPS-Candspecificitemsofthe
MADRS and IDS-SR assessing hedonic capacity. Similarly, we assessed its discriminant
validity by looking at items from the Montgomery-Asberg Depression Rating Scale
(MADRS;Montgomery&Asberg,1979)andInventoryofDepressiveSymptomatology-Self
Rating(IDS-SR;Trivedietal.,2004)thatarenotpresumedtobedirectlyrelatedtohedonic
capacity. In addition, we examined the reliability of the SHAPS-C by assessing its internal
consistencyandsplit-halfreliability.
MATERIALS AND METHODS
We studied 34 depressed subjects (18 males) with a mean age of 46.7 years (SD = 10.4,
range 24–63) who participated in depression studies at the National Institute of Mental
Health (NIMH), Bethesda, MD, under Institutional Review Board approved protocols
(01-M-0254) including written informed consent. Subjects were diagnosed based on a
best estimate diagnostic procedure that included psychiatric interview, assessment by
the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV-TR) patient edition (SCID I/P; First et al., 2002), and interview of
familymembersaswellasreviewofpasthistoryandrecordsasindicated.Subjectswhomet
criteria for current Major Depressive Disorder (MDD; n = 21) or Bipolar Disorder (BD,
n = 13) in the depressive phase participated. Subjects with current psychosis, cognitive
impairment, unstable medical conditions, or acute suicide risk were excluded. We also
excluded manic or hypomanic subjects (n = 2). Although the SHAPS-C can measure
increased pleasure, such a low number of subjects did not justify inclusion into the study.
All subjects completed the SHAPS-C, SHAPS, MADRS, and the IDS-SR (Table 1). The
sameclinicianadministeredtheMADRSandtheSHAPS-C.
Pearson correlations were calculated to better understand the concurrent validity of
the SHAPS-C. MADRS Inability to Feel (item 8) and IDS-SR General Interest (item 19)
and Capacity for Pleasure and Enjoyment (item 21) were examined in relationship to the
SHAPS-C total scores. Similarly, the discriminant validity of the SHAPS-C was assessed
by the level of correlation between MADRS Concentration (item 6), Energy (item 7),
and Pessimism/Guilt (item 9) and IDS-SR Concentration (item 15), Outlook Towards
Self (item 16), Energy (item 20), and Somatic Concerns (item 25), items that are not
presumed to be directly related to hedonic capacity. Significance was evaluated at p < .05,
two-tailed.Tohave80%powertodemonstrateacorrelationofatleastr = .50,aminimum
of 26 cases were required; 34 cases yielded 90% power. Finally, Cronbach’s alpha and the
Spearman–Browncoefficientwereusedtoexaminetheinternalconsistency,andsplit-half
reliabilityoftheSHAPS-C,respectively.
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N (%)
Diagnosis
Major depressive disorder 21 (62)
Bipolar disorder 13 (38)
Gender (Male) 18 (53)
Race (Caucasian) 21 (62)
Mean(SD)
Age 46.7 (10.4)
SHAPS-C total 41.9 (7.2)
SHAPS total 6.5 (4.3)
IDS-SR
Total 43.5 (12.0)
General interest 2.1 (0.9)
Capacity for pleasure/enjoyment 1.8 (0.7)
MADRS
Total 32.7 (6.3)
Inability to feel 3.8 (1.0)
Notes.
SHAPS-C, Snaith-Hamilton Pleasure Scale-Clinician Administered; IDS-SR, Inventory of Depressive Symptomatology-
Self Rating; MADRS, Montgomery-˚ Asberg Depression Rating Scale; SHAPS, Snaith-Hamilton Pleasure Scale.
RESULTS
The mean scores for the SHAPS-C, SHAPS, IDS-SR (total), and MADRS (total) for the
studysamplewere41.9(SD=7.2),6.5(SD=4.3),43.5(SD=12.0),and32.7(SD=6.3),
respectively(Table1).Thissuggestsamoderatetoseverelydepressedsample.
The SHAPS-C was internally consistent (Cronbach’s α = .90). Removing individual
items did not change the internal consistency substantially in either direction. The
Spearman–Brown split-half reliability was .90. In addition to evidence for the reliability
oftheSHAPS-C,wealsofoundsupportfortheSHAPSasaninternallyconsistentmeasure
(Cronbach’sα = .88,SpearmanBrown= .93).
The SHAPS-C was positively correlated with the SHAPS (r = .85, p < .001). Figure 1
illustrates this relationship and shows that patients had the full range of scores on the
SHAPS, but they did not reach the lower levels of the SHAPS-C. This was expected since
the lowest scores on the SHAPS-C would indicate higher than normal levels of pleasure
which is not expected in a group of moderate to severely depressed patients. Given the
overlap in the content of the questions for these scales, we examined the relationships
between corresponding items. Spearman correlations were used due to the short range of
values for the items. The correlations ranged from .37 to .73 with 12 of 14 items having
correlationsover.50.
Table 2 shows the relationships between the anhedonia (SHAPS-C, SHAPS) and
depression scales (MADRS, IDS-SR) (see Fig. 2). As predicted, the SHAPS-C and SHAPS
totals were significantly correlated with MADRS Inability to Feel (item 8) and IDS-SR
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clinician administered SHAPS-C and the self-administered SHAPS is apparent.
Figure 2 Association between the SHAPS-C and the MADRS. A strong positive relationship is visible
between the clinician administered SHAPS-C scale, which assess anhedonia, and the clinician adminis-
tered MADRS, which assesses general depressive symptomatology.
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SHAPS SHAPS-C
r p 95%CI r p 95%CI
SHAPS-C 0.85 <.001 0.71 0.92
IDS-SR
Total 0.52 0.003 0.20 0.74 0.55 0.001 0.25 0.76
Item 5 (Sad mood) 0.34 0.07 −0.02 0.62 0.47 0.007 0.15 0.70
Item 8 (Mood reactivity) 0.38 0.04 0.03 0.65 0.55 0.001 0.25 0.75
Item 9 (Mood variation) −0.21 0.27 −0.52 0.16 −0.25 0.17 −0.55 0.11
Item 15 (Concentration) 0.16 0.38 −0.20 0.49 0.15 0.40 −0.21 0.48
Item 16 (Outlook towards self) −0.19 0.32 −0.51 0.18 −0.13 0.48 −0.46 0.23
Item 19 (General interest) 0.39 0.03 0.04 0.66 0.48 0.006 0.15 0.71
Item 20 (Energy) 0.29 0.12 −0.08 0.58 0.31 0.08 −0.04 0.60
Item 21 (Capacity for pleasure
or enjoyment)
0.54 0.002 0.23 0.75 0.69 <.001 0.45 0.84
Item 25 (Somatic concerns) 0.19 0.31 −0.18 0.51 0.22 0.23 −0.14 0.53
MADRS
Total 0.52 0.003 0.20 0.73 0.56 0.001 0.27 0.76
Item 1 (Apparent sadness) 0.23 0.21 −0.13 0.53 0.48 0.005 0.16 0.70
Item 2 (Reported sadness) 0.44 0.01 0.11 0.69 0.49 0.004 0.18 0.72
Item 6 (Concentration) 0.16 0.40 −0.20 0.48 0.19 0.29 −0.16 0.50
Item 7 (Energy) 0.12 0.51 −0.24 0.45 0.21 0.23 −0.14 0.52
Item 8 (Inability to feel) 0.48 0.006 0.15 0.71 0.53 0.002 0.22 0.74
Item 9 (Pessimism/guilt) 0.06 0.75 −0.30 0.40 0.01 0.95 −0.33 0.35
Notes.
CPES, Snaith-Hamilton Pleasure Scale-Clinician Administered; SHAPS-C, Snaith-Hamilton Pleasure Scale-Clinician Administered; IDS-SR, Inventory of Depressive
Symptomatology Self Rating; MADRS, Montgomery Asberg Depression Rating Scale; SHAPS, Snaith-Hamilton Pleasure Scale.
General Interest (item 19) and Capacity for Pleasure or Enjoyment (item 21). These
relationshipssuggesttheconvergentvalidityoftheSHAPS-C.Interestingly,thecorrelation
between hedonic capacity and mood ranged from low to moderate indicating that mood
andhedoniccapacitycouldbeconsideredasrelativelyindependentconstructs.Specifically,
the correlation between SHAPS and SHAPS-C totals were less than .5 for MADRS
Apparent Sadness (item 1) and Reported Sadness (item 2), as well as with IDS-SR Sad
Mood (item 5) and Mood Variation (item 9). Only the relationship with IDS-SR Mood
reactivity (item 8) and SHAPS-C was just over .5. The SHAPS-C and SHAPS totals were
not significantly correlated with MADRS Concentration (item 6), Energy (item 7), or
Pessimism/Guilt (item 9), nor with the corresponding items of the IDS-SR Concentration
(item 15), Energy (item 20), or Outlook Towards Self (item 16). These non-significant
associationssupportthediscriminantvalidityoftheSHAPS-C.
DISCUSSION
In-depth measurement of hedonic capacity along with the measurement of mood and
behavior is important in depression treatment studies (Boyer et al., 2000). Self-
administered assessments may not be sufficient, particularly in severe psychiatric
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and self-report measures may be included since each can uniquely contribute to the
prediction of treatment outcome (Uher et al., 2012). This study introduces the SHAPS-C,
a clinician administered version of the SHAPS, and demonstrates its internal consistency,
split-half reliability, and convergent and discriminant validity with the SHAPS, MADRS,
and IDS-SR in a group of depressed patients for assessment of anhedonia. The SHAPS-C
was strongly positively correlated with the original SHAPS and with specific hedonic
itemsfromtheMADRSandIDS-SR,butnotnon-hedonicquestions.Thehighcorrelation
between the SHAPS and SHAPS-C suggests they tap into the same construct. However,
the size of the correlation indicates that about a third of the variance (r2 = .67) from one
is not explained by the other which may point to the uniqueness of a clinician measure.
However,itshouldbenotedthatweutilizedinternalconsistencyandsplit-halftoassessthe
reliability of SHAP-C, future studies may also want to consider test-retest reliability for a
morecompleteassessmentofreliability.
Similar correlations between the MADRS and SHAPS were reported in the original
studybySnaithetal.(1995)althoughtheiroriginalsampleof46patientswasnotlimitedto
depressedpatientsandincludedmixedpsychiatricdisordersthatdisplayedanhedonia.The
similarity between results from the initial SHAPS study and the current study suggest
that mood and hedonic capacity could be considered separate constructs and closer
attention should be paid to the assessment of hedonic capacity. In addition, laboratory
findings suggest that underlying neurobiological and neuropsychological substrates for
anhedonia may be useful in clarifying relevant endophenotypes of depression related to
anhedonia (Gottesman & Gould, 2003; Hasler et al., 2004; Pizzagalli et al., 2009; Pizzagalli,
Jahn & O’Shea, 2005). Hedonic tone may assist in elucidating links and differentiations
among various psychiatric disorders (Snaith et al., 1995) including bipolar conditions and
depressionsubtypes.
The present study has several limitations that future studies should address. While the
sample size of 34 yielded 90% power for the study, a larger sample size will be needed
to confirm the current findings. Non-significant correlations intended to demonstrate
divergent validity could be significant in a larger study which would cloud the arguments
for the uniqueness of the SHAPS-C. Future studies reporting on validity and reliability of
the SHAPS-C in larger clinical samples will help to clarify the usefulness of this measure
and provide more accurate estimates of the relationships between the SHAPS-C and
other measures. The subject population of the current study was limited to moderate
to severely depressed patients, the performance of the SHAPS-C in euthymic or mildly
depressedpatientsremainstobestudied.Includingeuthymicormildlydepressedpatients
would help us to better understand the utility of SHAPS-C across the full spectrum of
depression and hedonic capacity. There were no control groups in the current study. The
addition of various control groups in future studies will further enrich the interpretation
of current findings. In particular, assessment of hedonic capacity not only in depressive
states but also in manic or hypomanic states will require a tool for assessment in both
directions. SHAPS-C’s scoring and questions are designed such that a bidirectional
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well as a wider range of patient groups could provide normative information to establish
normal and pathological levels of hedonic capacity. Finally, since the same clinician
administered the clinician measures, the potential for clinician bias could have increased
the correlation between these measures which means the estimates of the relationships
could be overstated. However, this could be true for evaluations of convergent and
divergentvalidity.
In sum, exploration of hedonic capacity in diagnostic, clinical, and neurobiological
investigations requires valid and reliable tools. Given the controversy of self-assessments
in severe psychiatric disorders, including depression, and possible unique contribution of
self-assessments and clinician-assessments for prediction of outcome, the availability of a
user-friendlyclinician-administeredtoolforassessmentofanhedoniaisofpotentialvalue.
WeproposethatSHAPS-Ccouldbeconsideredsuchatool.
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